• Little has been published on cost progression for ALS patients • Insurer claims data can easily follow hundreds of patients from before diagnosis through death • Insurance data provide insight into:
-Patient disease progression -Costs before and after diagnosis -Costs and timing of supportive services and functional status progression -The extent to which decisions on respiratory and feeding support impact costs of care
Data Sources:
• Medical claims databases containing -Information on claims paid -Demographic information and identifiers to allow longitudinal tracking -Diagnosis, procedure and drug details using standard coding systems
• There is no othe r clinical information in the claims data • 368 ALS patients were identified from a 5% sample of Medicare claims
• 344 ALS patients were identified from the Truven Marketscan commercial database
Disability Milestone Definition:
The following codes in the claim data were used to determine when patients achieved the disability milestones.
Statistical Analyses:
• Demographic information and claims data were descriptively summarized
• Monthly claims costs were tabulated from one year before the index date until death or through 2010 and modeled exponentially
• Average costs from claims submitted for reimbursement were provided by periods relative to index dates and insurance program
• Patients whose initial diagnosis of ALS occurred while they were covered by Medicare were defined as "pure" Medicare
• Patients whose initial diagnosis of ALS occurred while they were covered by commercial insurance were included with commercial data
• To avoid complications from the often rapid transition from commercial insurance to Medicare, pure Medicare and commercial data were analyzed separately
• For pure Medicare cases, Kaplan-Meier Sample Average (KMSA) was employed to model cumulative costs … -From index date (i.e., diagnosis) until death or through 2010, adjusting for censored cases -From index date to disability milestones; different milestones with few cases of similar duration from index month were collapsed for analyses
The primary objective of this analysis was to characterize the medical care costs incurred for ALS patients covered by Medicare and by commercial insurance. Specific aims are:
• To determine the ALS costs before and after diagnosis for patients already under Medicare coverage 
